IMMUNIC INC (IMUX)

US4525EP1011 - Common Stock

1.24  +0.01 (+0.81%)

After market: 1.25 +0.01 (+0.81%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
0.000.000.000.000.00
Cost Of Goods
N/AN/AN/AN/AN/A
Gross Profit
N/AN/AN/AN/AN/A
Operating Expenses
99.22M86.52M74.42M48.97M37.03M
Research and Development
83.22M71.26M61.12M38.64M22.51M
Selling, General, and Administrative Expenses
16.01M15.26M13.30M10.33M14.52M
Operating Income
-99.22M-86.52M-74.42M-48.97M-37.03M
Interest Income/Expense
3.08M1.04M70.00K60.00K110.00K
Other Income/Expense
2.54M-1.96M-1.35M4.90M1.99M
Non Recurring Items
0.00-32.97M-17.25MN/AN/A
Income Before Taxes
-93.61M-120.41M-92.95M-44.02M-34.93M
Net Income
-93.61M-120.41M-92.95M-44.02M-34.93M
EBITDA
-99.11M-86.44M-74.33M-48.93M-36.98M
 
Per Share Data
EPS Diluted Total Ops
-2.11-3.78-3.93-2.81-4.52
Non GAAP EPS
-2.11-3.77-3.93-2.85N/A
 
Statistics

All data in USD

Charts